Global home infusion therapy market

Dublin, August 14, 2024 (GLOBE NEWSWIRE) — The report “Global Home Infusion Therapy Market Forecast Report By Product, Application, Countries and Company Analysis 2024-2032” has been added to The Offer.

The home infusion therapy market is expected to grow from $42.70 billion in 2023 to $72.84 billion by 2032, growing at a compound annual growth rate of 6.12% between 2024 and 2032.

The leading players in this field are involved in the manufacturing and supply of these products and are known for their inventions and solutions in the field of home infusion therapy.

Prospects for home infusion therapy

The process of administering medications and nutrients directly into the veins at home is called home infusion therapy. It addresses infections, dehydration, chronic diseases, pain relief and nutritional deficiencies. Conventional treatments include antibiotics, antivirals, chemotherapy, pain medications and intravenous nutrition.

This includes patients who require long-term treatment and patients who have mobility restrictions throughout treatment. They are cared for not through repeated hospital admissions, which can be inconvenient for patients, but through comprehensive care. It also protects patients from contracting other diseases during hospitalization and reduces the likelihood of hospitalization.

In particular, nurses and pharmacists are involved in coordinating medication administration to determine whether the treatment is effective for the patient and to minimize the occurrence of side effects. In this line of development, home infusion is increasingly seen in healthcare as a way to manage complex conditions and improve people’s overall quality of life by delivering therapy in the comfort of their own home rather than in the traditional clinic.

Driving forces for home infusion therapy

Ageing population: The growing geriatric population is the main reason for the use of home infusion therapy products worldwide. Patients suffer from chronic diseases such as diabetes, heart disease and cancer and therefore require continuous intravenous therapies regardless of their age. Home infusion therapy proves to be efficient and cost-effective in treating the said conditions and helps elderly patients to have a better quality of life as they do not have to go to the hospital as often. It is expected that more and more patients will opt for home care to manage their health conditions efficiently and conveniently.

Technological advances: Home infusion therapies are now very common as the development of medical technologies has improved the application of home infusions. Modern infusion pumps are mobile and have a very intuitive user interface. Some of them offer options such as remote monitoring and alarms. These features improve patient care and help avoid the oversights in providing appropriate treatment.

In addition, advances in telemedicine and healthcare on digital platforms have enabled healthcare professionals to monitor and coordinate patients receiving infusion therapy at home. These technologies have minimized the occurrence of complications, improved patient outcomes, and thereby increased home infusion therapy as a reliable form of treatment compared to traditional hospital care.

Rising healthcare costs: Hospital treatments and healthcare services are experiencing higher costs, shifting the focus to home infusion therapy as a strong market growth driver. This makes home care a better solution as it has lower costs in terms of hospital costs, transportation costs, and facility operating costs. As insurers and care management centers recognize the cost-effectiveness of home infusion therapy, continuous improvements in reimbursement systems and patient advocacy are being implemented by insurance companies and healthcare providers to support this treatment model. This shift in approach toward cost-effective care solutions is encouraging patients and healthcare organizations to embrace home infusion therapy, increasing the market size.

Patient preferences for home care: More and more patients prefer to receive treatment at home rather than going to the hospital which they prefer. During home infusion therapy, patients can enjoy their home environment which is confidential and comfortable, creating a more natural atmosphere compared to a clinic setting. This is one of the most common preferences of patients with diseases that require recurrent or prolonged medical care. It is also well known that a patient feels much more comfortable when receiving treatment in familiar surroundings as it reduces stress and improves overall satisfaction. This means that home infusion therapy is already appreciated and consumers are expanding this market.

Home Infusion Therapy Market in Asia Pacific

The home infusion therapy market in Asia Pacific will offer huge opportunities for development due to the growing demand for healthcare and technological advancements. China, Japan, India and Australia are mentioned as the countries playing a major role in this growth. The population is aging and becoming prone to chronic diseases such as diabetes, cancer and cardiovascular diseases that require long-term treatment, which is why home infusion therapy can be used profitably.

Human factors such as portable infusion pumps and telemedicine integration are some of the technological advancements that are improving patient comfort and treatment effectiveness. Moreover, the aging population and rising cost of care require efficient, patient-centric home care solutions. As for the factors driving the market growth, it is also important to point out that many countries have launched government programs and adopted more compassionate healthcare policies. Overall, numerous countries in the Asia Pacific region are expected to witness significant advancements in home infusion therapy to improve patient conditions and healthcare delivery.

Main features:

Analysis of the main players: Business overview, product portfolio, current developments and strategies, sales analysis

• Pfizer Inc.

• Smith & Nephew plc

• Terumo Corporation

• Johnson & Johnson Services, Inc.

• Becton, Dickinson and Company

• Baxter International Inc.

• Intensive care medicine

• Eli Lilly and Company

Product market breakdown from 4 perspectives:

• Infusion pump

• Intravenous sets

• IV cannulas

• Needleless connections

Application – Market segmentation in 7 perspectives:

Country – Market distribution of the 25 countries:

• North America

• United States

• Canada

• Europe

• France

• Germany

• Italy

• Spain

• United Kingdom

• Belgium

• Netherlands

• turkey

• Asia-Pacific

• China

• Japan

• India

• South Korea

• Thailand

• Malaysia

• Indonesia

• Australia

• New Zealand

• Latin America

• Brazil

• Mexico

• Argentina

• Middle East and Africa

• Saudi Arabia

• United Arab Emirates

• South Africa

• Rest of the world

For more information about this report visit https://www.researchandmarkets.com/r/x13lb0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900